Capricor Therapeutics, Inc.CAPRNASDAQ

Revenue (LTM)

-100.0% YoY

Net Income (LTM)

$-105M

-159.6% YoY

Free Cash Flow

$-72.7B

Revenue CAGR (5Y)

—

Marginsimproving

FCF($72.7B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	3↑941.8%	25↑886.8%	22↓11.5%	0
Gross Profit	0	-19↓7966.7%	-11↑41.5%	-28↓145.8%	0
Operating Income	-21	-30↓41.8%	-24↑18.9%	-43↓76.8%	-108↓154.1%
Net Income	-20	-29↓44.9%	-22↑23.2%	-40↓81.6%	-105↓159.6%
EBITDA	-21	-29↓40.9%	-23↑21.1%	-41↓78.8%	-108↓162.9%
EPS Diluted	-0.87	-1.18↓35.6%	-0.83↑29.7%	-1.15↓38.6%	-2.26↓96.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	35	10↓72.5%	15↑53.0%	11↓23.2%	288↑2450.3%
Total Current Assets	36	43↑17.7%	51↑18.6%	163↑221.3%	323↑97.7%
Total Assets	41	50↑21.2%	59↑17.2%	170↑190.3%	356↑108.8%
Total Current Liabilities	4	24↑470.6%	31↑32.6%	21↓32.8%	36↑70.4%
Total Liabilities	10	38↑284.5%	36↓5.7%	25↓30.8%	50↑100.5%
Total Equity	31	12↓62.4%	23↑91.8%	145↑543.6%	306↑110.2%
Total Debt	3	3↓10.8%	2↓12.7%	1↓35.1%	21↑1343.4%
Net Debt	-32	-7↑78.0%	-12↓76.9%	-10↑21.1%	-267↓2613.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-17	5↑129.2%	-26↓620.6%	-40↓56.3%	-69,811↓174446.7%
Capital Expenditure	-1	-3↓180.8%	-2↑39.1%	-2↑24.8%	-2,904↓188627.0%
Free Cash Flow	-18	2↑108.6%	-28↓1875.6%	-42↓50.2%	-72,716↓174972.1%
Stock-Based Comp	3	4↑50.3%	7↑65.8%	10↑32.1%	16,968↑173658.5%
Net Change in Cash	2	-25↓1239.1%	5↑120.1%	-3↓166.9%	276,560↑8115463.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance